StockNews.com cut shares of Elevance Health (NYSE:ELV – Free Report) from a buy rating to a hold rating in a research note ...

Shares of Elevance Health Inc. ELV slipped 1.42% to $405.40 Tuesday, on what proved to be an all-around great trading session ...

In a report released today, Stephen Baxter from Wells Fargo maintained a Buy rating on Elevance Health (ELV – Research Report), with a price ...

Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $492.5, with a ...

Early Tuesday, the White House budget office circulated a 52-page document as it seeks to implement a sweeping freeze of federal assistance, ...

Wall Street Breakfast, Seeking Alpha's flagship daily business news summary, is a one-page summary that gives you a rapid overview of the day's key financial news. It is designed for easy ...

The companies raised prices a median 4%, though some drugs will cost thousands of dollars more.

Highlights:,Elevance Health's stock has experienced a dip in value.,The company maintains a moderate debt-to-equity ratio and ...

Key earnings reports from Apple, Microsoft, Meta, and Tesla will provide insights into their financial health and future ... it comes to moderation. The Wall Street Journal says executives reached ...